Stock ownership · SEC 13F · Q4 2025

SUPERNUS PHARMACEUTICALS INC

Who owns SUPERNUS PHARMACEUTICALS INC (CUSIP 868459108)? A look at the institutions behind it, how tightly they hold it, and the latest quarter's moves.

$2.4M
Reported value
4
Institutions
100%
Top-5 share

The verdict

As of Q4 2025, 4 institutions report $2.4M in SUPERNUS PHARMACEUTICALS INC positions, ownership that is dominated by its top few institutional owners.

4
institutions hold it
$2.4M
reported 13F value
100%
held by top 5

Based on long positions reported to the SEC as of Q4 2025; 13F omits shorts, options and non-US holdings.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP 868459108 · Q4 2025 $2M reported

VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-LIGHT · BOOK-MID

  • VALUE-TRACE $2.4M
  • HOLDERS-FOCUS 4 filers
  • CONC-DOM 100% top-5
  • PHOTO-UNK No peer
  • ACTIVITY-LIGHT 1 new
  • BOOK-MID 7Q history

Read with: Ownership concentration guide - SUPERNUS PHARMACEUTICALS INC's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Largest institutional holders of SUPERNUS PHARMACEUTICALS INC
  1. 1
    Villanova Investment Management Co LLC $2.4M
  2. 2
    Pacer Advisors, Inc. $9K
  3. 3
    Bell Investment Advisors, Inc $4K
  4. 4
    TD Capital Management LLC $199

Top 4 reported holders by value · Q4 2025

Institutional ownership over time

The number of institutions reporting a SUPERNUS PHARMACEUTICALS INC position has risen from 1 to 4 over the last 7 quarters of 13F filings.

012345 Q1'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25 4
Distinct 13F filers holding SUPERNUS PHARMACEUTICALS INC, by quarter

Top Institutional Holders

# Institution Shares Value Share of reported
1 Villanova Investment Management Co LLC 48,054 $2.4M 99.5%
2 Pacer Advisors, Inc. 172 $9K 0.4%
3 Bell Investment Advisors, Inc 75 $4K 0.2%
4 TD Capital Management LLC 4 $199 0.0%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among SUPERNUS PHARMACEUTICALS INC's reported holders for Q4 2025, by reported value:

Sole discretion (SOLE)
100.0%

Latest Quarter Activity · Q4 2025

New positions (1)

TD Capital Management LLC $199

Frequently Asked Questions

How many institutions hold SUPERNUS PHARMACEUTICALS INC?▼
SUPERNUS PHARMACEUTICALS INC is held by 4 institutional investors per the latest SEC Form 13F filings as of Q4 2025.
What is the total institutional value of SUPERNUS PHARMACEUTICALS INC?▼
Institutions report $2.4M of SUPERNUS PHARMACEUTICALS INC as of Q4 2025.
How concentrated is ownership of SUPERNUS PHARMACEUTICALS INC?▼
The top five institutional holders account for 100% of the reported institutional value in SUPERNUS PHARMACEUTICALS INC, making ownership dominated by its top few institutional owners.
Who is the largest institutional holder of SUPERNUS PHARMACEUTICALS INC?▼
Villanova Investment Management Co LLC is the largest reported holder of SUPERNUS PHARMACEUTICALS INC with $2.4M across 48,054 shares as of Q4 2025.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-09-26.